Image - 3 November 2020

Peetra Magnusson

Peetra Magnusson, researcher at the Department of Immunology, Genetics and Pathology, Uppsala University

License:: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:: .jpg
Size:: 960 x 1280, 1.27 MB

Download

Contacts

Elin Bäckström
Press contact Press Officer Research Education elin.backstrom@uu.se +46-70-425 09 83
Linda Koffmar
Press contact Press Officer linda.koffmar@uu.se +46 (0)18-471 19 59
Sandra Gunnarsson
Press contact Press Officer sandra.gunnarsson@uu.se +4673 469 75 92

30 March 2022 07:45
Inflammation and net-like protein structures in cerebral cavernous malformations

In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers at Uppsala University show in a new study that white blood cells and protein structures associated with the immune response infiltrate the vessel lesions.
23 February 2021 10:35
Beta blockers can repair malformed blood vessels in the brain

Propranolol, a drug that is efficacious against infantile haemangiomas (“strawberry naevi”, resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by researchers at Uppsala University in a new study published in the scientific journal Stroke.
3 November 2020 13:22
Venous origin of brain blood-vessel malformations

In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can now show, at molecular level, that these changes originate in vein cells. This new knowledge of the condition creates potential for developing better therapies for patients. The study has been published in the journal eLife.